3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Failure
1
Hepatitis C
1
Hepatitis B
1
Hepatic Insufficiency
1
HIV Infections
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Fluorouracil
2
Etoposide
2
Cyclophosphamide
2
liposomal doxorubicin
1
fludarabine
1
dehydroftorafur
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
axicabtagene ciloleucel
1
Zidovudine
1
X-Rays
1
Vincristine
1
Valganciclovir
1
Triage
1
Therapeutics
1
Standard of Care
1
Sodium Chloride
1
Smoking Devices
1
Sirolimus
1
Sigmoidoscopy
1
Sentinel Lymph Node Biopsy
1
Rituximab
1
Restraint, Physical
1
Raltegravir Potassium
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Raltegravir Potassium
×
1 year
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled